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Targeted expression of step-
function opsins in transgenic rats 
for optogenetic studies
Hiroyuki Igarashi1,12, Keiko Ikeda2,3, Hiroshi Onimaru4, Ryosuke Kaneko5, Kyo Koizumi6, 
Kaoru Beppu7, Kayo Nishizawa8, Yukari Takahashi9, Fusao Kato  9, Ko Matsui7, Kazuto 
Kobayashi8, Yuchio Yanagawa5, Shin-Ichi Muramatsu  10,11, Toru Ishizuka6 & Hiromu Yawo1,6
Rats are excellent animal models for experimental neuroscience. However, the application of 
optogenetics in rats has been hindered because of the limited number of established transgenic rat 
strains. To accomplish cell-type specific targeting of an optimized optogenetic molecular tool, we 
generated ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats that conditionally express the 
step-function mutant channelrhodopsin ChRFR(C167A) under the control of extrinsic Cre recombinase. 
In primary cultured cortical neurons derived from this reporter rat, only Cre-positive cells expressing 
ChRFR(C167A) became bi-stable, that is, their excitability was enhanced by blue light and returned 
to the baseline by yellow~red light. In bigenic pups carrying the Phox2B-Cre driver, ChRFR(C167A) 
was specifically expressed in the rostral parafacial respiratory group (pFRG) in the medulla, where 
endogenous Phox2b immunoreactivity was detected. These neurons were sensitive to blue light with 
an increase in the firing frequency. Thus, this transgenic rat actuator/reporter system should facilitate 
optogenetic studies involving the effective in vivo manipulation of the activities of specific cell fractions 
using light of minimal intensity.
Understanding the neural system of the brain by revealing the interconnected networks and their emerging func-
tions is a major aim of neuroscience. Previously, the mapping of brain circuits was conducted using pharmacolog-
ical or electrical stimulation methods. Although electrical stimulation enables temporally precise control of the 
neuronal activity, the spatial resolution is not high because of the widespread electric field in brain tissue. In addi-
tion, it is difficult to differentially stimulate a specific type of neuron in the network. By contrast, the discovery of 
channelrhodopsins, algal photoreceptor proteins1,2, prompted the generation of photosensitive neurons geneti-
cally engineered to express channelrhodopsins3,4. This state-of-the-art technology, referred to as optogenetics, is 
now indispensable to modern neuroscience owing to its genetic selectivity, high spatiotemporal precision and low 
invasiveness5–8. When extending this method to animal models, both the satisfactory expression of engineered 
opsin genes in a genetically defined cell type and the delivery of light at a specific wavelength must be achieved9,10.
Recently, various transgenic mice have been created to enable optogenetic studies of the neural mechanisms 
underlying behaviours11,12. However, larger rodent models are required to investigate higher-order brain func-
tions. The rat is a favourable non-human model system13 that offers potential advantages over mice because of 
their larger body size and superior ability to accomplish complex behavioural paradigms14,15. For example, rats 
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can accommodate a large number of electrodes and LED fibres to record the resultant neuronal activity from 
multiple sites in vivo in response to the stimulation of multiple neurons16.
One of the original representative transgenic rat strains expressing an optogenetic molecular tool is the 
thy1.2-ChR2-Venus line (W-TChR2V4)17–20. Although this line can enable the specific targeting of ChR2 to ret-
inal ganglion cells, dorsal root ganglion neurons, and various neurons in the hippocampus and cerebral cortex 
under the regulation of the thy1.2 promoter, a conditional expression system with optimized opsins is needed 
to establish a generalizable approach. With respect to the conditional expression system, a panel of the Cre 
recombinase-driver rat lines was introduced for the optogenetic targeting of genetically defined cell types using 
virus vectors incorporating the genes of interest in the downstream portion of relatively strong promoters8,21. 
However, since this method relies on a virus injection strategy, the number and location of neurons that express 
the optogentic molecular tools often diverge among animals. Therefore, practical reporter strains of rats that con-
ditionally express optogenetic molecular tools under a Cre-loxP system are highly desired.
Regarding the optimization of opsin genes, many natural opsins have been identified, and their utilization has 
been improved through molecular modifications6,10,22. Among these molecules, point mutations of the so-called 
DC gate, comprising C128 and D156 of ChR2 or their counterparts, substantially affect the photocycle kinetics 
of channelrhodopsins to become bi-stable (step-function opsins, SFOs). That is, the step-function mutants are 
typically activated in response to light, such as blue light, remaining open in the dark for an extended period and 
shutting down in response to another light, such as yellow or violet light23,24. Thus, step-function mutants are 
highly sensitive to dim light and behave like photon accumulators, making these molecules attractive candidates 
for in vivo optogenetics using large animals.
Here, we generated a novel transgenic actuator/reporter rat strain expressing one of the well-characterized 
step-function mutants of chimaera channelrhodopsins, ChRFR(C167A)25, in the presence of exogenous Cre 
recombinase (ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rat). The ChRFR(C167A)-expressing 
neurons from this rat were sensitive to dim blue light, increasing neural excitabilities both in vitro and in the 
brain ex vivo. These new transgenic rat strains will contribute to a wide range of biomedical studies through the 
optogenetic modulation of targeted cellular activity in vivo.
Results
Cre-dependent expression of ChRFR(C167A)-Venus. We established and characterized a transgenic 
actuator/reporter rat strain, (ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rat), carrying three copies 
of genome constructs with the ChRFR(C167A)-Venus gene downstream of a floxed STOP cassette containing the 
neomycin–resistant gene and four repeats of the polyadenylation sequence (Fig. 1A). The gene was controlled 
under the cytomegalovirus enhancer/chicken β-actin promoter (CAG promoter) at the ROSA26 site of a mouse 
BAC containing the ROSA26 gene26. After loxP site-specific excision of the STOP cassette, ChRFR(C167A) 
tagged with the yellow fluorescent protein Venus27 was expressed under the CAG promoter. PCR analysis con-
firmed that the transgenic (Tg) rats possessed a neo cassette. Rats with the 726-bp band were considered floxed 
STOP-positive and used for further experiments (Fig. 1B).
Actuator/Reporter gene expression by the transfection of exogenous Cre gene. To examine the 
conditional expression of ChRFR(C167A)-Venus, we injected adeno-associated virus 2 (AAV2)-Cre virus vectors 
into the striatum or hippocampus of heterozygous rats (n = 3) obtained by crossing male ROSA26/CAG-floxed 
STOP-ChRFR(C167A)-Venus BAC rats with wild-type female Long-Evans (LE) rats. At 3 weeks post-injection, 
Venus fluorescence was detected at all injection sites, and the signals were closely confined to the injection points 
(Fig. 2A, Supplementary Fig. S2). By contrast, the expression of Venus was not detected on the other side of the 
hemisphere, which underwent PBS injection. At higher magnification, Cre signals were clearly detectable in the 
nuclei, and Venus signals were accumulated in the plasma membrane of those cells; importantly, these signals did 
not merge with each other (Fig. 2B).
Robustness of the actuator/reporter system. To validate the Cre-dependent expression in this actua-
tor/reporter line, primary cultured cortical neurons of ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC 
rats were transfected with plasmids containing mCherry-NCre28. The mCherry-positive nuclei and Venus-positive 
plasma membranes were detected only in cells (n = 28) prepared from Tg-positive embryos (n = 5). By con-
trast, cells (n = 59) expressing mCherry-NCre prepared from Tg-negative siblings (n = 6) did not express 
ChRFR(C167A)-Venus (Fig. 3A,B). An unexpected STOP excision in loxP-based reporter animals is referred 
to as leaky expression29,30. To detect leaky expression in this actuator/reporter system, the DNA template was 
extracted from homogenized whole brains of ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats, and 
each allele in the BAC construct, with (497 bp) or without the STOP sequence (314 bp), was amplified using PCR. 
As a positive control, the DNA template extracted from the medullary tissue of bigenic pups obtained by cross-
ing ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats and Phox2b_tTA-2A-Cre driver rats (Fig. 3C) 
was used. Only a single band corresponding to the allele with the STOP sequence was detected in the actuator/
reporter rat, indicating that background recombination was negligible (Fig. 3D). In subsequent experiments, a 
subpopulation of cortical neurons expressing ChRFR(C167A)-Venus under the control of the CaMKIIα pro-
moter was used for the whole-cell patch clamp experiments.
Regulation of neuronal activity using two colours of light. It was well anticipated that the excitability 
of a neuron from the ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats could be manipulated by light 
when it expressed Cre. The excitability of a neuron in the primary culture was tested by current ramp injections 
under whole-cell current clamp (Fig. 4A). At first, the slope of a ramp was adjusted to generate several action 
potentials. Next, the same current ramp was injected after illumination with blue light (500 ms, 438 ± 24 nm) and 
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then red light (8 s, 643 ± 20 nm, 6.8 mWmm−2) starting after the current ramp injection. In every Cre-positive 
neuron (n = 16), the membrane potential was depolarized solely by blue light in a manner dependent on the 
power (Supplementary Fig. S3). Although this depolarization was accompanied by action potentials in two of 
them, it was not in the others (n = 14) even at the maximal power of light (3 mWmm−2). However, the time to 
evoke the first action potential (tAP) was significantly reduced during the current ramp injection by the preceding 
blue light in the Cre-positive neurons, but not in the Cre-negative neurons (Fig. 4B,C). On the other hand, when 
the primary culture was made from the littermate embryo without the transgenic allele, neither the depolarization 
nor the reduction of tAP was induced by any light even in the Cre-positive neurons (Fig. 4D).
Directive expression using Phox2B Cre-driver rats. Phox2b is a paired-like homeobox-encoding gene 
and a key regulator of autonomic neural crest derivatives and placode-derived visceral sensory ganglia. Phox2b 
is also expressed in pre-inspiratory (Pre-I) neurons in the parafacial respiratory group, constituting one of the 
respiratory rhythm generators in the medulla of newborn rats31,32. We previously reported that the expression of 
PHOX2B is a remarkable feature of Pre-I neurons and a useful marker for identifying the cytoarchitecture of neu-
rons in the pFRG in the newborn rat medulla33. Newborn pups expressing ChRFR(C167A)-Venus under the con-
trol of Phox2b enhancer/promoter were obtained by crossing ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus 
BAC rats with Phox2b_tTA-2A-Cre-driver rats (Fig. 3C). The functional expression of ChRFR(C167A) was eval-
uated in the newborn, bigenic rat for the following three issues. First, we investigated whether the Venus-positive 
Figure 1. Generation of ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC actuator/reporter rats. 
(A) The transgene construct, which was inserted into the mouse ROSA26 BAC clone, comprised the CAG 
promoter, a cassette for the neomycin resistance gene with four STOP signal repeats (pA) flanked by loxP 
sites, and a sequence containing the ChRFR-C167A open reading frame. After Cre-mediated recombination, 
ChRFR(C167A)-Venus expression was under the regulation of the generic CAG promoter. (B) PCR analysis 
of genomic DNA. The 726-bp band, which is recognized by the designed primer sets targeting the PGK-neo 
cassette sequence between two loxP sequences, was present in the ChRFR(C167A)-Venus reporter rats but not 
in the wild-type rats. A 100-bp DNA ladder was used as marker (M). A full uncropped image is available as 
Supplementary Figure S1A.
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signals driven by Cre recombinase could be observed in Pre-I neurons of the pFRG. A Venus-positive signal 
was detected in the rostral pFRG in the superficial area just ventral to the facial nucleus (FN) in the medulla, 
where endogenous Phox2b immunoreactivity was detected (Fig. 5). Second, we compared the expression pattern 
of ChRFR(C167A)-Venus in Phox2b-Cre/floxed ChRFR(C167A) with that of tdTomato in Phox2b-Cre/floxed 
STOP tdTomato bigenic neonatal rats15 (Supplementary Figs S4, S5). The expression of ChRFR(C167A)-Venus 
was consistently detected, and the expression patterns of the actuator were coincident with those of tdTomato 
throughout the brainstem-spinal cord sections. The reliability of this Cre-dependent recombination was further 
evaluated using VGAT-Cre BAC rat (NBRP-0839, Supplementary Fig. S6). Even in other brain regions such as the 
hippocampus, cortex, cerebellum, and striatum in the bigenic rats, the expression of ChRFR(C167A)-Venus was 
successfully induced and coincident with the distribution of GABAergic neurons. Third, the effects of photostim-
ulation were examined on the Phox2b positive pFRG neurons in the ex vivo brainstem-spinal cord preparation 
(n = 6, Fig. 6). The Phox2b-positive neurons were depolarized in the membrane potential with increased excit-
ability during and after photostimulation by blue LED. Indeed, the firing frequency was significantly increased 
upon blue light stimulation. The neuronal excitability was up-regulated for several seconds after the end of pho-
tostimulation, but returned to baseline in tens of seconds (Fig. 6D).
Figure 2. Viral vector-mediated reporter gene expression in striatum. (A) Confocal image of brain 
sections stained with antibodies against Cre (magenta) and GFP (Green). The ROSA26/CAG-floxed STOP-
ChRFR(C167A)-Venus BAC actuator/reporter rat was injected with AAV2-Cre in its striatum. (B) Localization 
of Cre-immunoreactive nuclei (magenta) and Venus immunoreactivity (green) in neurons at striatum. (C) 
Orthogonal view on the brain image stack of a neuron which has Cre-positive nucleus. Note that Venus 
accumulated in the plasma membrane and did not merge with the Cre signals.
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Discussion
Here, we demonstrated the efficient and sensitive Cre-mediated expression of actuator/reporter genes in 
ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats. The strict regulation of ChRFR(C167A)-Venus 
expression by Cre recombinase was supported on the following grounds: (1) ChRFR(C167A) conjugated with 
the fluorescent marker Venus was expressed only in neurons transfected with Cre after AAV2-Cre injection; (2) 
ChRFR(C167A)-Venus was exclusively expressed in primary cultured cortical neurons containing Cre; and (3) 
ChRFR(C167A)-Venus was only expressed in neurons expressing Cre under a cell type–specific promoter using 
Figure 3. Robustness of the reporter system. (A) The primary cultured cortical neurons were prepared from 
both Tg-positive and negative littermates, and mCherry-NCre was transfected using calcium phosphate 
method; Venus fluorescence (green) and mCherry-NCre (magenta). (B) Comparison of the fraction of double-
positive cells with ChRFR(C167A)-Venus and mCherry-NCre between littermates (Tg, n = 5 pups; wild-type, 
n = 6 pups). For each group, 25 fields of interest were randomly chosen, and the cell number was counted 
in a double-blind manner. *p < 0.001, Student’s paired t-test. (C) Structure of the Phox2b_tTA-2A-Cre BAC 
transgene. The exon-intron structure of the Phox2b gene is shown in the upper part. The first exon that contains 
noncoding (a white rectangle) and coding (a black rectangle) regions, the second exon (a black rectangle), 
and the third exon which contains coding (a black rectangle) and noncoding (a white rectangle) regions are 
indicated as I, II, and III, respectively. The recombination targeted the first exon (around the ATG site of Phox2b 
gene) by inserting the tTA, 2 A peptide, and Cre recombinase with nuclear localization signal (NLS) coding 
sequences attached the rabbit ß globin gene polyadenylation sequence at 3′ end. (D) PCR assay of the genomic 
DNA extracted from the homogenized whole brain of a ChRFR(C167A)-Venus actuator/reporter rat. The allele 
of BAC with STOP sequence was detectable as 497 bp band. In the bigenic rat with Phox2B-Cre driver, 314 bp 
band became manifest as expected by the removal of Neo-STOP sequence. A full uncropped image is available 
as Supplementary Figure S1B.
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the Phox2b_tTA-2A-NLS-Cre BAC and VGAT-Cre BAC transgenic strain. Our results indicate that the cells car-
rying the active promoter could be selectively labelled with Venus fluorescence and effectively depolarized by 
light by combining these actuator/reporter rats with an appropriate driver rat strain. Although ChRFR(C167A) 
was well characterized in the photocurrent kinetics and its photocurrent was more dependent on Na+ and Ca2+ 
than H+ like ChR1 and 234,35 (Supplementary Fig. S8A and S8B, Supplementary Table S2), the validity of this sys-
tem should be checked in each case for the practical expression in various subpopulations of neurons. It should 
also be noted that the ON/OFF kinetics of a photocurrent is dependent on the cellular environment such as tem-
perature and pH2 as well as the molecular state of rhodopsin36,37.
Rats and mice have frequently been used as fundamental model organisms for biomedical research. Although 
similar in many aspects, there are several obvious differences between these rodent species in functional anat-
omy, physiology, and pharmacology38. Interestingly, the characteristics of Phox2b-expressing cells in the 
parafacial region of neonatal rats are basically similar to those in mouse, but the roles in respiratory rhythm 
generation during development are distinct39. Thus, the establishment of a reliable transgenic system in rats for 
Figure 4. Optical manipulation of excitability of neurons from the ROSA26/CAG-floxed STOP-
ChRFR(C167A)-Venus BAC actuator/reporter rat. (A) Typical recordings from the primary cultured cortical 
neurons in which ChRFR(C167A)-Venus was expressed by the transfection of CaMKIIα-mCherry-NCre 
plasmid: (top) the recording from transgenic positive (Tg(+)) neuron, (middle) current ramp injection, 
(bottom) Light stimulation paradigm for blue light (blue line, 438 ± 24 nm, 3 mWmm−2) and red light (red 
line, 643 ± 20 nm, 6.8 mWmm−2). (B) Overlay of representative traces of current injection without (black) and 
with blue light irradiation (magenta). (C) Relative time to evoke the first action potential (tAP) to that without 
light was calculated for each trace and plotted as a function of light power density. The change of this value 
was statistically tested using paired raw data before calculation using Wilcoxon signed rank test (†P < 0.01 and 
††P < 0.001). The fitting line was drawn according to the Michaelis-Menten relationship (Kd = 0.04 mWmm−2, 
Vmax = 0.27). (D) Summary of relative tAP value (tAP of light(+)/tAP of light(−)) in each population: Tg(−)/
Cre(+),Tg(+)/Cre(−) and Tg(+)/Cre(+). *P < 0.0005, Mann-Whitney U-test. Values are mean ± SEM.
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further studies has been desired, and the two BAC Tg lines introduced herein, namely, ROSA26/CAG-floxed 
STOP-ChRFR(C167A)-Venus BAC rats and Phox2b_tTA-2A-Cre driver rats, would contribute to expanding the 
repertoire and offer an attractive means for precise optogenetic targeting.
The application of an optogenetic approach to larger animal models has been challenging because the light 
has to be widely delivered to activate an entire substructure of larger size. To overcome this problem, the animal 
model has to accommodate a substantial number of modified optic fibres that deliver strong light into a wider 
region in the tissue, or the photocurrent properties, including the light sensitivity of the opsins, have to be opti-
mized. In one of the well-characterized step-function variants of ChRs, ChRFR(C167A), the magnitude of the 
photocurrent was approximated by a function of the turning-on (ON) rate constant, which is equivalent to τON−1, 
and the irradiation time25. Therefore, even light at a weak power could effectively depolarize the neuronal mem-
brane to become excitable with prolongation of the irradiation time. In the present study, ChRFR(C167A) was 
highly sensitive to blue light (50% activation; 0.08 mWmm−2, Supplementary Fig. S3), which was less than 1/10 of 
the power required for 50% activation of native channelrhodopsin-2 (1.3 mWmm−2)40. When all synaptic inputs 
of the cultured cortical neurons from our ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats were 
pharmacologically blocked, the light-evoked depolarization was often subthreshold even with the maximal power 
in the Cre-positive neurons. However, the excitability of a neuron was actually increased by light as evidenced by 
the reduction of tAP. That is, the light should cause some of the sub-threshold EPSPs to become excitable in neu-
rons in the network. Indeed, the irradiation of weak blue light (0.1-0.2 mWmm−2) onto the brainstem-spinal cord 
of rat neonates was sufficient to enhance the excitability of neurons in the pFRG (Fig. 6). To our knowledge, this 
actuator/reporter system is the first successful use of a step-function mutant channelrhodopsin in a transgenic 
rat. With the temporally precise tuning of the membrane potentials, this rat line is optimized for an experimental 
context that requires modulation of the spontaneous firing rate rather than the generation of every action poten-
tial23,41. For instance, the transition from a hyperpolarized to a depolarized state of the membrane potential is 
usually accompanied by a peculiar pattern of electrical activity intrinsic to its neuronal subclass42,43. The relevance 
of the periodic oscillations in a genetically defined cell population to the specific behavioural outcome could be 
directly tested by simply alternating the delivery of blue or red light into the targeted region44.
In summary, this actuator/reporter rat strain enables the control of identified neuronal activity by light under 
the visualization of Venus fluorescence. It appears to be suitable to optically manipulate deep in the tissue, since 
the spectral sensitivity of ChRFR(C167A) is more red-shifted than the SFOs derived from ChR225 and the brain 
Figure 5. Expression of ChRFR(C167A)-Venus in the bigenic rat with Phox2B-Cre driver. (A) Venus 
fluorescence image at lower magnification. FN, facial nucleus; pFRG, parafacial respiratory group. The light blue 
square denotes the area of B-D. (B) Venus; (C) anti-Phox2b immunofluorescence; (D) merge. Cell group of the 
pFRG is in an area indicated by a dotted line in B. Most Phox2b positive cells express Venus.
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tissue preferentially absorbs short wavelengths of light45. With the above-mentioned advantages and strengths of 
the relatively large body size and complex behaviour of rats, the transgenic lines reported herein would facilitate 
a variety of medical studies, including neuroscience.
Methods
Construction of ROSA26/CAG-floxedSTOP-ChRFR(C167A)-Venus BAC. The ROSA26/CAG-floxed 
STOP-ChRFR(C167A)-Venus BAC was generated using a BAC recombineering method15,46 with a BAC clone 
containing the mouse ROSA26 locus. Briefly, a BAC clone (RP23-244D9) from a C57BL/6 J mouse genomic 
BAC library (BACPAC Resource Center, Oakland, CA, USA) spanning ~183 kb upstream of ROSA26 exon 1 
to ~34 kb downstream of ROSA26 exon 3 (total size: ~226 kb) was used. To modify the Rosa26 locus, a cas-
sette containing the following components was constructed: a CAG promoter derived from pCAGGS47, loxP, 
FRT-flanked Kan/Neo cassette (from J. Takeda, Osaka University), 4 × poly(A) (from M. Yamamoto, Gunma 
University), ChRFR-C167A cDNA48, and SV40 poly(A). Through lambda red protein-mediated homologous 
recombination in E. coli EL25049, the above-mentioned cassette flanked by homologous fragments was inserted 
into the ROSA26 BAC clone at the desired location. The following primers were used to generate 5′ and 3′ homol-
ogy regions: R5-FS, gtcgaCGTCGTCTGATTGGCTCTC and R5-RX, ctcgaGACTGGAGTTGCAGATCAC for 
the 5′ homology region; and R3-FS, gtcgACAGTGTCGCGAGTTAGA and R3-RX, ctcgagCACCTGAACTTTG-
CATTCC for the 3′ homology region. The recombinants were identified after screening for kanamycin resistance, 
followed by PCR analysis. The following primers were used to assess the integrity of the recombination: R5upF2, 
CGTCTCGTCGCTGATTGGCTTC and CAG-R2, CCGTAAATAGTCCACCCATTGACG for the 5′ site; and 
G/RFPtail-F, CATGGACGAGCTGTACAAG and R3dwnR2, ATGCCATGAGTCAAGCCAG for the 3′ site. The 
loxP site and lox511 site in the pBACe3.6 backbone were removed, and the PI-SceI site was inserted using a BAC 
Figure 6. Optical manipulation of neural excitability in the central nervous sytem (CNS). (A) A sample pFRG 
neuron which was immunoreactive with Phox2b (red) and stained with Lucifer yellow in the patch electrode 
(green). (B) membrane potential trajectory during photostimulation (460–470 nm, 0.1–0.2 mWmm−2, duration 
50 ms, interval 150 ms, 6.7 Hz). Upper trace (Vm), membrane potential; lower trace (St), photostimulation 
given as a train of light pulses. (C) Similar to B, but the response of another neuron to shorter train of 
photostimulation pulses. Note that the time scale is different. (D) Summary of neuronal excitability (n = 6). The 
firing frequency was compared at different time points of photostimulation: before photostimulation (the first 
column), 3 s after photostimulation (the second column), 3 s after end of photostimulation (the third column) 
and 15 s after end of photostimulation. †P < 0.005, Wilcoxon signed rank test.
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recombineering method with the PIsac-mLK cassette (from R. Kaneko, Gunma University) or the d4PI511zeo 
cassette (from R. Kaneko, Gunma University), respectively.
Generation of ROSA26/CAG-floxedSTOP-ChRFR(C167A)-Venus BAC Tg rats. Recombined 
ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BACs were linearized by PI-SceI digestion and subsequently 
gel purified50. The purified BAC fragment was microinjected into the pronuclei of Long–Evans (LE) rat oocytes 
as previously described49. Among the 289 oocytes injected, 238 cells could be transferred into pseudo-pregnant 
female rats, and 52 pups were obtained. Nine ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC Tg 
founders were identified from the 52 weaned pups, and one of the lines is described herein. The BAC trans-
genic rats were maintained on an LE genetic background (Institute for Animal Reproduction, Ibaraki, Japan) and 
deposited to the National BioResource Project for the Rat in Japan (NBRP-Rat) (http://www.anim.med.kyoto-u.
ac.jp/nbr/default.aspx) as LE-Tg(Gt(ROSA)26Sor-CAG-COP4*C167A/YFP*)1Jfhy (NBRP-0840).
Detection of transgene recombination. Genomic DNA was extracted using a standard method51 or sim-
ple alkali isolation. In the alkali extraction, the animal tissue was immersed in 50 mM NaOH and subsequently 
vortexed. After heating for 10 min at 95 °C, the solution was neutralized using 1 M Tris-HCl, followed by centrifu-
gation. Only the supernatant was used for the subsequent PCR experiments. Genomic DNA was used as the tem-
plate for PCR to detect the transgene using the following primer: 5′-CTATGACTGGGCACAACAGACAAT-3′ 
(in the Neo resistance gene-coding region). To evaluate the effectiveness of recombination, DNA was extracted 
from homogenized whole brains. Each allele with/without a STOP sequence was PCR-amplified using either set 
of primers: pCX1624F, CTAGAGCCTCTGCTAACC and PGK-R, GACGTGCTACTTCCATTTGTCAC for the 
STOP-remaining allele (PCR product: 497 bp); or pCX1624F, CTAGAGCCTCTGCTAACC and ChR + 136 R, 
CTCGGTGGAAGACGTAATCAGG for the STOP-deleted allele (PCR product: 314 bp). The PCR fragments 
were amplified at 95 °C for 3 min, followed by 35 cycles at 95 °C for 30 sec, 60 °C for 30 sec, and 72 °C for 1 min 
using KOD FX Neo (TOYOBO, Osaka, Japan). GeneRuler 100 bp DNA ladder (Fermentas, Burlington, ON, 
Canada) was used as marker for electrophoresis.
Viral expression of Cre recombinase. For histological evaluation, the rats were anaesthetized using 
sodium pentobarbital (50 mg/kg, i.p.) and were injected with the viral vector. The vector solution (0.5 μl, 
1.03 × 1013 vector genomes/ml) or PBS (0.5 μl/site) was injected into 8 sites of the dorsal striatum through a glass 
microinjection capillary connected to a micro-infusion pump (ESP-32; Eicom, Kyoto, Japan), which was stereo-
taxically introduced using the coordinates according to an atlas of the rat brain52. The anteroposterior, mediolat-
eral, and dorsoventral coordinates (millimetres) from the bregma and dura were 1.5/3/3 (site 1), 1.5/3/3.5 (site 
2), 0.5/3/3 (site 3), 0.5/3/3.5 (site 4), 1.5/−3/3 (site 5), 1.5/−3/3.5 (site 6), 0.5/−3/3 (site 7), and 0.5/−3/3.5 (site 
8). Injection was performed at a constant flow rate of 0.1 μl/min using a micro-infusion pump. For the slice patch 
clamp experiment, the rats underwent the surgery when 21–40 days old. The animals were anaesthetized using 
ketamine/xylazine (50 and 10 mg/kg, respectively, intramuscularly) and placed in a stereotaxic frame. The scalp 
was incised and a 1–2-mm craniotomy was made over each injection coordinate point. The AAV2 virus express-
ing Cre under the cytomegalovirus promoter (4.5 × 1011 vector genomes/mL) was used as previously described53. 
The virus (1.5 μl) was pressure injected at each injection point in the hippocampus. The scalp was closed using a 
fast-acting cyanoacrylate adhesive (Aron alpha A; Sankyo, Tokyo, Japan).
Primary culture of cortical neurons. Female LE rats were mated with male ROSA26/CAG-floxed 
STOP-ChRFR(C167A)-Venus BAC rats, and cortical neurons were isolated from the embryos at day 16. 
Cortical tissue was dissociated using a 2.5% Trypsin and 0.5% DNase I mixture and grown in culture medium 
(Sumitomo Bakelite, Tokyo, Japan) under a 5% CO2 atmosphere at 37 °C. The expression plasmid mCherry-NCre 
was transiently transfected in cortical neurons using calcium phosphate transfection at 6–7 days in vitro (DIV). 
Electrophysiological recordings were subsequently conducted at 21–25 DIV in neurons identified to express 
mCherry fluorescence under a conventional epifluorescence system.
To evaluate the recombination efficiency, 25 fields (218.9 μm2) of interest showing mCherry positive nuclei 
from wells (Nunc, cat. no. 176740) in each group were selected. Double blind counting was applied to detect cells 
positive for both Venus enhanced by Alexa-488 and mCherry enhanced by Alexa-546.
Electrophysiology. All experiments were conducted at room temperature (23 ± 2 °C). Photocurrents were 
recorded as previously described3 using an EPC-8 amplifier (HEKA Electronic, Lambrecht, Germany) under a 
whole-cell patch clamp configuration. The data were filtered at 1 kHz, sampled at 100 kHz (Digdata1440 A/D, 
Molecular Devices Co., Sunnyvale, CA) and stored in a computer (pClamp10.3, Molecular Devices). The internal 
pipette solution for the whole-cell voltage-clamp and current-clamp recordings from primary cultured cortical 
neurons contained (in mM) 4 KOH, 2 MgCl2, 20 KCl, 115 K-gluconate, 0.2 EGTA, 10 HEPES, 5 Mg-ATP, 0.3 
Na2GTP, 20 phosphocreatine and 50 U/ml creatine phosphokinase adjusted to pH 7.3 with KOH. The extra-
cellular ACSF solution contained (in mM) 125 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 
11 glucose, bubbled with mixed gas containing 95% O2 and 5% CO2. In all cortical neuron experiments, ACSF 
contained 3 mM kynurenic acid (Sigma, St. Louis, USA) and 100 μM picrotoxin (Nacalai, Kyoto, Japan) to block 
all synaptic inputs. Under whole-cell mode the resting potential was directly measured under current clamp and 
those neurons which had resting potentials of less than −50 mV served for the experiments (Supplementary 
Table S1). To investigate the excitability of a neuron the current ramp injection of 0.4–2 nA/s was made twice 
with an interval of 6 s through the patch electrode to depolarize the membrane potential above the threshold of 
generating action potentials.
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Optics. Irradiation was performed using a SpectraX light engine (Lumencor Inc., Beaverton, Oregon, USA) 
controlled by computer software (pCLAMP10.3, Molecular Devices) at wavelengths (nm, >90% of the maximum, 
maximal irradiance): 438 ± 24 (max. 3.0 mWmm−2, blue) and 643 ± 20 (max. 6.8 mWmm−2, red). The power 
density (irradiance) of the light was directly measured under microscopy by a visible light-sensing thermopile 
(MIR-101Q, SSC Co., Ltd., Kuwana City, Japan). To excite the primary culture neurons, blue irradiation was atten-
uated using ND filters at 50%, 25% and 5%. Closing kinetics of ChRFR(C167A) was evaluated using red light at 
the maximal irradiance (Supplementary Fig. S7). It followed a single exponential function with an OFF time con-
stant (τOFF) of 1080 ± 56 ms with a negligible component of the steady state photocurrent (Imax = −251 ± 46 nA, 
C = −17 ± 5 nA, n = 11). Therefore, the light-induced depolarization was almost completely attenuated by irradi-
ating red light at the maximal irradiance for 8 s; the photocurrent was expected to be attenuated by 93.4% at the 
end of red light irradiation.
Generation of transgenic Phox2b_tTA-2A-NLS-Cre BAC rats. The Phox2b_tTA-2A-NLS-Cre 
BAC (referred to as Phox2b_tTA-2A-Cre) transgenic construct was generated after integrating tandem cas-
settes of genes encoding a tetracycline transactivator (pTet-Off-Advanced, Clontech, Mountain View, CA), 2 A 
peptide, and Cre recombinase with a nuclear localization signal into clone 95M11 derived from the CHORI 
RP-24 C57BL/6 J (B6) mouse genomic library using the Red/ET recombination system (Gene Bridges GmbH, 
Heidelberg, Germany)54. A previous study showed that the 95M11 BAC clone contained the necessary regulatory 
regions required for the proper expression of the Phox2b gene in mice55. Phox2b_tTA-2A-Cre transgenic rats 
were generated by the pronuclear injection of Wistar rat embryos (Charles River Laboratory Japan Inc., Japan). 
Transgenic founders carrying the transgenic construct were assessed using Southern blotting. No obvious gross 
phenotypic differences were apparent between the transgene-positive and transgene-negative littermates. Several 
transgenic founder rats were bred with Wistar rats. Subsequent analyses were performed using one line (line 
3_19). Phox2b_tTA-2A-Cre rats were mated with ROSA26/CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats, 
and the newborn rats were used in subsequent experiments.
All animal experiments were approved by the Tohoku University Committee for Animal Experiments 
(Approval No. 2014LsA-023) and the Animal Research Committee of Showa University (56010). Experiments 
were performed in accordance with the Guidelines for Animal Experiments and Related Activities of Tohoku 
University and the guiding principles of the Physiological Society of Japan and the National Institutes of Health 
(NIH), USA. The number of animals in the present study was kept to a minimum. To minimize suffering, the 
rats were deeply anaesthetized with isoflurane in a glass bottle until nociceptive reflexes induced by tail pinch 
were completely abolished. Animals were provided access to food and water ad libitum and maintained under a 
12-hour light-dark cycle.
Ex vivo electrophysiology. Experiments were performed with brainstem-spinal cord preparations from 
newborn pups (0 to 3 days old) obtained after crossing Phox2b_tTA-2A-Cre RecBAC rats with ROSA26/
CAG-floxed STOP-ChRFR(C167A)-Venus BAC rats. The newborn rats were deeply anaesthetized with isoflu-
rane, and the brainstem and spinal cord were isolated as previously described56–58. In most experiments, the 
preparations were cut transversely at a level just rostral to the anterior inferior cerebellar artery, corresponding 
to the level between the roots of the sixth cranial nerve and the lower border of the trapezoid body. The prepara-
tions were continuously superfused with artificial cerebrospinal fluid (ACSF56) (composition [in mM]: 124 NaCl, 
5 KCl, 1.2 KH2PO4, 2.4 CaCl2, 1.3 MgCl2, 26 NaHCO3, 30 glucose, equilibrated with 95% O2 and 5% CO2, pH 
7.4) at a rate of 2.5–3 ml/min in a 2-ml chamber and maintained at a temperature of 25–26 °C. The inspiratory 
activity corresponding to phrenic nerve activity was monitored from the fourth cervical ventral root (C4). The 
rostral ventrolateral medulla corresponding to the pFRG was photostimulated by blue LED (460–470 nm, 0.1–0.2 
mWmm−2) via an optic fibre with a 0.25-mm outer diameter for up to 35 s (50 ms duration/150 ms interval). The 
membrane potential was −44.8 ± 3.9 mV, and input resistance was 683 ± 205 MΩ (n = 6). The recorded neurons 
located in the rostral pFRG were labelled with Lucifer Yellow and identified as Phox2b positive. All data analyses 
were performed using LabChart 7 Pro software (ADInstruments, Castle Hill, Australia).
Immunohistochemistry. Adult rat brains were resected three weeks after AAV2-Cre injection and 
promptly sectioned at 20 μm using a VT 1000S vibratome (Leica). Tissue slices were fixed with 4% paraform-
aldehyde, reacted with anti-Cre (1:500, MAB3120, Millipore) and anti-GFP (1:1000, 04404–84, Nacalai) anti-
bodies, followed by secondary antibodies conjugated with Alexa Fluor 546 (1:200, Z25004, Molecular Probes, 
Eugene, OR, USA) and Alexa Fluor 488 (1:200, A11006, Molecular Probes, Eugene, OR, USA), respectively. 
Immunoreactivity was assessed under conventional fluorescence microscopy (Axiovert200, Carl Zeiss) or con-
focal microscopy (LSM510META, Carl Zeiss or FV1200, Olympus). The brainstem-spinal cords of rat neonates 
were also subjected to immunostaining after electrophysiological study. The preparations were fixed in 4% par-
aformaldehyde/0.1 M phosphate-buffered saline (PBS, pH 7.4) at 4 °C for 3 hrs. and immersed in 18% sucrose/
PBS, embedded in Tissue-Tek optimal cutting temperature (OCT) compound (Sakura Finetek, Torrance, CA), 
frozen on dry ice, and subsequently cut into 18-μm-thick sections, followed by immunofluorescence imaging. 
Anti-Phox2b (1:2000 dilution33) and anti-Lucifer Yellow (Thermo Fisher Scientific/Invitrogen, Waltham, MA) 
were used for the primary antibodies, and Cy3-conjugated anti-guinea pig (Jackson ImmunoResearch, Baltimore 
Pike, West Grove, PA) and Alexa Fluor 488 anti-rabbit (Molecular Probes/Thermo Fisher Scientific, Eugene, OR) 
were used for the secondary antibodies. Images of the immunofluorescence samples were obtained using the 4× 
or 20× objectives of a BX51 fluorescence microscope (Olympus Optical). In each figure, the top is the dorsal side. 
The experiments were performed several times using different neonates, and the results were compatible between 
samples. Representative results are shown in the figures.
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Statistical analysis. All data in the text, figures and tables are expressed as mean ± SEM and were evaluated 
with the Mann-Whitney U-test for statistical significance unless otherwise noted. It was judged as statistically 
insignificant when P > 0.05.
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